Clinical Discovery Group

Page Image

Page Content

​The Clinical Discovery Group
provides insight on unmet medical needs related to fibrosis, potential
common mechanisms of fibrosis between different organ systems, clinical trial
development, and possible therapeutic approaches. Furthermore, the Clinical
Discovery Group is instrumental in biobanking human material, characterizing
human fibrotic tissue and fibrogenic cells, and correlating the molecular data
obtained with these samples to hard clinical endpoints. Finally, members of this group play a central role in designing and executing Phase
IIa Proof-of-Concept (POC) clinical trials to assess novel therapeutic
strategies in humans with fibrotic diseases. ​​​​​​​